Company: DVAX
Filing Date: 2025-02-14
Form Type: 8-K
Source: 0001029142-25-000031
Chunk: 1

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-02-14
Form: 8-K
Item: Item 5.02
Chunk 1
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

O n February 13, 2025, the Board of Directors of the Company appointed Kelly MacDonald, the Company’s Chief Financial Officer and principal financial officer, as the Company’s principal accounting officer, effective immediately.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                             Dynavax Technologies Corporation  
  Date:      February 14, 2025      By:      /s/ RYAN SPENCER                  
                                             Ryan Spencer